FDA Inspection 1206514 — Medi-Fare Drug
The FDA completed an inspection of Medi-Fare Drug on May 26, 2023 in Blacksburg, SC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 26, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Blacksburg, SC (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 1434 | 21 CFR 211.42(c)(10)(iv) | Environmental Monitoring System |
| 1724 | 21 CFR 211.134(b) | Representative samples after completion |
| 1833 | 21 CFR 211.84(d)(1) | Identity Testing of Each Component |
| 4314 | 21 CFR 211.84(d)(2) | Reports of Analysis (Components) |